SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000891092-10-005550
Filing Date
2010-12-06
Accepted
2010-12-06 10:54:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A e40937sc13ga.txt SC 13G/A 8885
  Complete submission text file 0000891092-10-005550.txt   10775
Mailing Address 4520 EAST-WEST HIGHWAY, SUITE 300 BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, SUITE 300 BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Subject) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-83614 | Film No.: 101233351
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3-11 NIHONBASHI-HONCHO 2-CHOME CHUO-KU TOKYO M0 103-8411
Business Address 3-11 NIHONBASHI-HONCHO 2-CHOME CHUO-KU TOKYO M0 103-8411 81-3-3244-3231
Astellas Pharma Inc. (Filed by) CIK: 0001376684 (see all company filings)

IRS No.: 132971791
Type: SC 13G/A